EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glycation Leads to Increased Invasion of Glioblastoma Cells

Paola Schildhauer, Philipp Selke, Christian Scheller iD, Christian Strauss, Rüdiger Horstkorte, Sandra Leisz iD, Maximilian Scheer iD

Cells · 2023

DOI: 10.3390/cells12091219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Paola Schildhauer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany. Hauptthemen laut MEDLINE: Glioblastoma, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Halle Doctoral College in Medicine (HaPKoM), Medical Faculty of Martin Luther University Halle-Wittenberg, DFG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is a highly aggressive and invasive brain tumor with a poor prognosis despite extensive treatment. The switch to aerobic glycolysis, known as the Warburg effect, in cancer cells leads to an increased production of methylglyoxal (MGO), a potent glycation agent with pro-tumorigenic characteristics. MGO non-enzymatically reacts with proteins, DNA, and lipids, leading to alterations in the signaling pathways, genomic instability, and cellular dysfunction. In this study, we investigated the impact of MGO on the LN229 and U251 (WHO grade IV, GBM) cell lines and the U343 (WHO grade III) glioma cell line, along with primary human astrocytes (hA). The results showed that increasing concentrations of MGO led to glycation, the accumulation of advanced glycation end-products, and decreasing cell viability in all cell lines. The invasiveness of the GBM cell lines increased under the influence of physiological MGO concentrations (0.3 mmol/L), resulting in a more aggressive phenotype, whereas glycation decreased the invasion potential of hA. In addition, glycation had differential effects on the ECM components that are involved in the invasion progress, upregulating TGFβ, brevican, and tenascin C in the GBM cell lines LN229 and U251. These findings highlight the importance of further studies on the prevention of glycation through MGO scavengers or glyoxalase 1 activators as a potential therapeutic strategy against glioma and GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaGliomaBrain NeoplasmsHumansMaillard ReactionMagnesium OxideNeoplastic Processes

Stichwörter der Autor:innen

advanced glycation end-productsastrocytesglioblastomagliomaglycationinvasionmethylglyoxal

Substanzen

Magnesium Oxide

Autor:innen und Institutionen

  • Department of Neurosurgery, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany.
  • Institute for Physiological Chemistry, Medical Faculty, Martin-Luther-University Halle-Wittenberg, 06114 Halle (Saale), Germany.

ORCID-Profile: Christian Scheller, Sandra Leisz, Maximilian Scheer

Förderung

  • Halle Doctoral College in Medicine (HaPKoM)
  • Medical Faculty of Martin Luther University Halle-Wittenberg
  • DFG

Zitieren

APA

Schildhauer, P., Selke, P., Scheller, C., Strauss, C., Horstkorte, R., Leisz, S., & Scheer, M. (2023). Glycation Leads to Increased Invasion of Glioblastoma Cells. Cells. https://doi.org/10.3390/cells12091219

Vancouver

Schildhauer P, Selke P, Scheller C, Strauss C, Horstkorte R, Leisz S, et al. Glycation Leads to Increased Invasion of Glioblastoma Cells. Cells. 2023. doi:10.3390/cells12091219

BibTeX
@article{Schildhauer2023,
  author = {Schildhauer, Paola and Selke, Philipp and Scheller, Christian and Strauss, Christian and Horstkorte, Rüdiger and Leisz, Sandra and Scheer, Maximilian},
  title = {Glycation Leads to Increased Invasion of Glioblastoma Cells},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12091219}
}
Kostenlos starten →